1. Home
  2. GIB vs DGX Comparison

GIB vs DGX Comparison

Compare GIB & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CGI Inc.

GIB

CGI Inc.

HOLD

Current Price

$92.42

Market Cap

19.5B

ML Signal

HOLD

Logo Quest Diagnostics Incorporated

DGX

Quest Diagnostics Incorporated

HOLD

Current Price

$182.89

Market Cap

20.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GIB
DGX
Founded
1976
1967
Country
Canada
United States
Employees
N/A
N/A
Industry
Professional Services
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.5B
20.5B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
GIB
DGX
Price
$92.42
$182.89
Analyst Decision
Hold
Buy
Analyst Count
3
15
Target Price
$117.00
$194.07
AVG Volume (30 Days)
333.4K
1.2M
Earning Date
11-05-2025
10-21-2025
Dividend Yield
0.48%
1.75%
EPS Growth
0.55
14.49
EPS
5.28
8.51
Revenue
$11,424,213,683.00
$10,850,000,000.00
Revenue This Year
$8.32
$12.37
Revenue Next Year
$4.41
$3.52
P/E Ratio
$16.79
$21.44
Revenue Growth
8.43
13.74
52 Week Low
$84.00
$148.70
52 Week High
$122.79
$197.55

Technical Indicators

Market Signals
Indicator
GIB
DGX
Relative Strength Index (RSI) 65.72 44.87
Support Level $87.95 $184.18
Resistance Level $89.50 $185.12
Average True Range (ATR) 1.52 3.22
MACD 0.60 -0.78
Stochastic Oscillator 91.53 3.85

Price Performance

Historical Comparison
GIB
DGX

About GIB CGI Inc.

CGI is a Canada-based IT-services provider with an embedded position in North America and Europe. The company is one of the major IT suppliers to different levels of government around the world. It offers a broad portfolio of services such as consulting, systems integration, application maintenance, and business process services to governments and the private sector. With offices in over 40 countries, CGI follows a balanced global delivery model with most consultants in client proximity.

About DGX Quest Diagnostics Incorporated

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

Share on Social Networks: